Russell Investments Group
DTIL icon

Russell Investments Group’s Precision BioSciences DTIL Stock Holding History

Russell Investments Group’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,043
Closed -$96K – 2905
2022
Q1 		$96K Buy
1,043
+588
+129% +$79.9K ﹤0.01% 2568
2021
Q4 		$100K Sell
455
-2,696
-86% -$753K ﹤0.01% 2838
2021
Q3 		$1.09M Sell
3,151
-282
-8% -$95.6K ﹤0.01% 2148
2021
Q2 		$1.29M Buy
3,433
+2,001
+140% +$601K ﹤0.01% 2183
2021
Q1 		$444K Buy
1,432
+399
+39% +$140K ﹤0.01% 2571
2020
Q4 		$257K Sell
1,033
-215
-17% -$52.7K ﹤0.01% 2678
2020
Q3 		$230K Buy
1,248
+1,181
+1,763% +$235K ﹤0.01% 2722
2020
Q2 		$16K Buy
+67
New +$14.7K ﹤0.01% 3066

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Russell Investments Group's DTIL Position: Q2 2022 in Review

Russell Investments Group sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 1,043 shares — an estimated $96K sold.

Russell Investments Group first reported a position in DTIL in Q2 2020 and held it in 8 quarters. The position peaked at $1.29M in Q2 2021. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

  • Russell Investments Group reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
  • Russell Investments Group sold 1,043 Precision BioSciences shares in Q2 2022, an estimated $96K.
  • Russell Investments Group first reported a position in Precision BioSciences in Q2 2020 and held it in 8 quarters.
  • Russell Investments Group's Precision BioSciences position peaked at $1.29M in Q2 2021.
  • 119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on Russell Investments Group's 13F filing for Q2 2022, filed 29 Jul 2022.